Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission.

Acute coronary syndrome Myocardial infarction Outcome Resource utilization Troponin

Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
26 04 2023
Historique:
received: 02 08 2022
revised: 25 12 2022
accepted: 19 01 2023
medline: 17 5 2023
pubmed: 26 1 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

Many patients with suspected non-ST-elevation (NSTE) acute coronary syndromes (ACS) are admitted, even those with initial high-sensitivity cardiac troponins (hs-cTn) values who meet rapid rule-out criteria for myocardial infarction (MI). We examined the clinical outcomes, resource utilization, and diagnostic yield of suspected NSTE-ACS patients, who presented with hs-cTnT values meeting these criteria but were nevertheless hospitalized. Applying the 2020 European Society of Cardiology (ESC) rapid rule-out MI criteria, we identified consecutive patients with an initial value of hs-cTnT <5 ng/L or an initial value of ≥5 ng/L but <14 ng/L (99th percentile) and a small increment in a subsequent test, who were nevertheless admitted. The majority (85.4%) of patients presented to the emergency department (ED) with suspected NSTE-ACS had an initial hs-cTnT <99th percentile. We examined 3775 admitted patients out of 11 477 patients who were triaged and met MI rule-out criteria. Only 0.32% (12 patients) of admitted patients experienced index MI or overall death within 30 days. Resource utilization in terms of ED stay, hospital stay, noninvasive and invasive tests was substantial, yet revascularization was uncommon (2.5%). Multivariate adjustment for age, gender, and baseline cardiovascular risk factors demonstrates similar survival of admitted vs. discharged patients (P = 0.88). Initial hs-cTnT even below the 99th percentile provided a prognostic stratification for long term mortality. Our findings support a policy of ED discharge of suspected NSTE-ACS patients meeting rapid MI rule-out criteria and subsequent ambulatory evaluation, sparing resource-consuming admissions. In-hospital and ensuing prognosis were better with lower initial hs-cTnT values.

Identifiants

pubmed: 36694945
pii: 7000829
doi: 10.1093/ehjqcco/qcad003
doi:

Substances chimiques

Troponin T 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-215

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Ben Cohen (B)

Cardiology Department, Rabin Medical Center, Petah Tikva, 4941492,Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.

Sharon Cohen (S)

Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.
Department of Laboratory Medicine, Rabin Medical Center, Petah Tikva, 4941492, Israel.

Ruth Tor (R)

Department of Laboratory Medicine, Rabin Medical Center, Petah Tikva, 4941492, Israel.

Tzippy Shochat (T)

Bio-Statistical Unit, Rabin Medical Center, Petah Tikva, 4941492, Israel.

Shmuel Fuchs (S)

Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.
Cardiology Institute, Shamir Medical Center, Tzrifin, 6093000, Israel.

Ran Kornowski (R)

Cardiology Department, Rabin Medical Center, Petah Tikva, 4941492,Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.

Alon Grossman (A)

Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.
Rabin Medical Center, Department of Internal Medicine B, Petah Tikva, 4941492, Israel.

David Hasdai (D)

Cardiology Department, Rabin Medical Center, Petah Tikva, 4941492,Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH